Vancomycin Injection 1 Gram ADD-Vantage Vials, 10/Box by Pfizer (Rx)

Vancomycin Hydrochloride 1 Gram Injection is an antibiotic used to treat serious bacterial infections, particularly those caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and other resistant strains. It is often administered intravenously for infections such as pneumonia, septicemia, skin infections, and endocarditis. Vancomycin works by inhibiting cell wall synthesis, ultimately killing the bacteria. It is crucial in clinical settings where standard antibiotics are ineffective.

Vancomycin Hydrochloride Injection is a glycopeptide antibiotic used to treat serious or severe infections caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and other infections where other antibiotics are ineffective. The formulation is provided by Pfizer Injectables in the form of 1-gram ADD-Vantage vials, which are designed for reconstitution and immediate attachment to an IV bag. This packaging offers convenience for healthcare providers in hospital settings, ensuring timely preparation and administration.

Details and Features

Active Ingredient: Vancomycin Hydrochloride
Dosage Form: Powder for injection
Strength: 1 gram per vial
Packaging: 10 ADD-Vantage vials per box
Usage: Designed for intravenous administration after reconstitution
Manufacturer: Pfizer Injectables
Purpose: Treatment of serious gram-positive bacterial infections, especially in hospitalized patients

Mechanism of Action

Vancomycin works by inhibiting bacterial cell wall synthesis. It binds specifically to the D-alanyl-D-alanine terminus of cell wall precursor units, blocking the action of enzymes involved in forming peptidoglycan structures critical for bacterial cell walls. This disrupts cell wall integrity, causing bacterial cell death, especially in cases of gram-positive bacteria that are resistant to other antibiotics.

Warnings

• Ototoxicity: Vancomycin has the potential to cause hearing loss, particularly in patients with pre-existing hearing issues or those who receive high doses. Routine auditory testing is advised for patients at risk.
  
• Nephrotoxicity: There is a risk of kidney damage, especially when administered concomitantly with other nephrotoxic drugs. Monitor renal function regularly.
  
• Infusion Reactions: Rapid infusion can lead to "red man syndrome," a condition characterized by flushing, rash, and sometimes hypotension. This is mitigated by slower infusion rates (over at least 60 minutes).
  
• Drug Interactions: Use caution in patients taking other nephrotoxic or ototoxic agents.
  
• Specific Populations: Dose adjustments may be needed for elderly patients or those with renal impairment due to altered pharmacokinetics.

Side Effects

Common Side Effects:

• Red or flushed skin ("red man syndrome")
• Injection site pain or inflammation
• Mild rash or allergic reactions

Serious Side Effects:

• Hearing loss or tinnitus
  
• Significant renal impairment or acute kidney injury
  
• Severe allergic reactions: Difficulty breathing, swelling of the face or throat
  
• Neutropenia or other blood-related issues with prolonged use

Administration and Monitoring

Vancomycin Hydrochloride should be administered intravenously, typically over a period of at least 60 minutes to avoid reactions associated with rapid infusion. Healthcare providers should monitor patients' kidney function and auditory function, particularly for therapies extending beyond the typical course or in at-risk patients. Blood levels of vancomycin can be measured to ensure therapeutic yet non-toxic concentrations, facilitating appropriate dose adjustments. Proper aseptic techniques should be used during preparation and reconstitution, adhering to all guidelines for safe compounding and administration.